MedTrace Logo

Minima Clinical Study

NCT02414542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-04-23

No results posted yet for this study

Summary

Post-marketing clinical study,international, multi-centre, prospective, observational. The investigation will be carried out in 2 sites in Europe for a maximum total number of 160 patients.The aim of this study is to assess clinical, radiographic and subjective outcomes after hip arthroplasty with a cementless metaphyseal MINIMA short stem, define the survivorship of the implant and identify possible risk factors that may lead to failure.

Conditions

  • Total Hip Arthroplasty

Interventions

DEVICE

MINIMA stem

Sponsors & Collaborators

  • Limacorporate S.p.a

    lead INDUSTRY

Principal Investigators

  • Luigi Zagra · I.R.C.C.S. Galeazzi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-12-31
Completion
2023-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02414542 on ClinicalTrials.gov